Compare MIST & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | SRBK |
|---|---|---|
| Founded | 2003 | 1887 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.9M | 149.8M |
| IPO Year | 2019 | 2023 |
| Metric | MIST | SRBK |
|---|---|---|
| Price | $0.83 | $19.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 13.5K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $43.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.75 | $14.34 |
| 52 Week High | $3.06 | $20.95 |
| Indicator | MIST | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 29.06 | 37.98 |
| Support Level | N/A | $19.09 |
| Resistance Level | $1.42 | $20.16 |
| Average True Range (ATR) | 0.06 | 0.29 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 18.27 | 16.07 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.